Skip to content
Start your journey

After breast cancer treatment

Follow-up mammograms, hormone therapy for five to ten years, lymphoedema, bone and heart health, and the symptoms worth reporting between appointments.

4 min read · Part of Cancer Types

Written by The LifeAfterward editorial team from the sources listed at the end of this page.

Not individually reviewed by a clinician. This page is written from published clinical guidance, listed in full at the end, and is general information rather than medical advice — your own team knows your case. See our editorial standards.

Last checked against its sources · Last updated · Next check due

In short

  • Follow-up usually combines annual mammography with clinical review; routine scans of the rest of the body are not standard for people without symptoms.
  • Hormone therapy typically runs for five to ten years and is where most of the ongoing side-effect burden sits.
  • Lymphoedema risk continues for life after lymph node surgery or radiotherapy, and early treatment works much better than late.
  • Bone and heart monitoring matter — particularly with aromatase inhibitors, anthracyclines, HER2-targeted drugs or left-sided radiotherapy.

What this means

Breast cancer follow-up is long, mostly low-intensity, and centred on imaging of breast tissue plus management of treatment effects. The two things that most affect day-to-day life afterwards are hormone therapy side effects and the physical consequences of surgery and radiotherapy — both of which have far more solutions than people are usually told.

What follow-up usually looks like

  • Annual mammography of remaining breast tissue, generally continuing for many years. After mastectomy without reconstruction, the treated side is examined rather than imaged.
  • Clinical review, often annually, sometimes on a patient-initiated pathway with a fast route back in.
  • Ongoing prescription and review of hormone therapy, where relevant.
  • Bone density (DXA) monitoring on aromatase inhibitors, and heart monitoring after anthracyclines, trastuzumab or chest radiotherapy.
  • Routine whole-body scans and tumour markers are not standard follow-up for people without symptoms — this reflects evidence, not cost-cutting.

Living with hormone therapy

Tamoxifen, aromatase inhibitors and ovarian suppression meaningfully reduce recurrence risk, and a substantial number of people stop early because of side effects — often without telling anyone. Almost every side effect has an approach.

  • Joint and muscle pain: exercise helps; switching between agents is often possible.
  • Hot flushes and night sweats: non-hormonal options exist, but some interact with tamoxifen — see menopause after cancer.
  • Vaginal dryness and painful sex: moisturisers, lubricants and, in discussion with your team, low-dose vaginal oestrogen.
  • Bone thinning on aromatase inhibitors: DXA, calcium and vitamin D, weight-bearing exercise, and bone-protecting medication where indicated.
  • Mood and sleep: treatable, and worth raising.

Lymphoedema and the arm

  • Report any swelling, heaviness, tightness or a sleeve that suddenly feels snug — early treatment is far more effective. See lymphoedema after cancer treatment.
  • Ask for referral to a lymphoedema service rather than waiting for it to declare itself.
  • Exercise, including progressive resistance training, is now supported rather than avoided; build up gradually with advice.
  • Look after the skin: treat cuts promptly, and seek advice quickly for redness, heat or fever in the affected arm, which can indicate cellulitis.
  • Shoulder stiffness and cording after surgery respond well to physiotherapy — ask.

What to report between appointments

  • A new lump or thickening in either breast, the chest wall, armpit or above the collarbone.
  • Skin changes: dimpling, redness, rash on the breast or scar, or nipple change.
  • Persistent bone pain, particularly in the back, hips or ribs, especially if it wakes you.
  • Persistent cough or breathlessness, or unexplained weight loss.
  • New arm swelling, or redness and heat in an at-risk arm.

What to ask your healthcare team

  • What is my follow-up schedule, and when is my next mammogram?
  • How long will I be on hormone therapy, and what are the options if side effects are difficult?
  • Do I need a DXA bone scan or heart monitoring, and how often?
  • Can I be referred to a lymphoedema service, and what should I watch for?
  • What symptoms should make me contact you rather than wait?
  • Should my family be considering genetic testing?

Save questions to My Journey so you have them in the room, or use a ready-made list.

When to seek medical advice

Contact your healthcare team if you have:

  • A new lump or skin change in the breast, chest wall or armpit.
  • Persistent bone pain, especially at night.
  • New arm or hand swelling.
  • Persistent cough, breathlessness or unexplained weight loss.

Get emergency help the same day if you have:

  • A red, hot, painful arm with fever — possible cellulitis, needs same-day treatment.
  • New back pain with leg weakness, numbness or bladder or bowel changes.

If you are worried and unsure, contact your team anyway — they would far rather hear from you unnecessarily than late. What to do in an emergency.

Common questions

How often will I have mammograms after breast cancer?

Usually annually on remaining breast tissue, continuing for many years. Your own schedule depends on your surgery, age and risk, so ask your team to write it down along with who books it.

Why am I not having regular body scans after breast cancer?

Routine scanning of people without symptoms has not been shown to improve survival in early breast cancer, and it produces false alarms and unnecessary procedures. Follow-up therefore relies on mammography, examination and prompt reporting of symptoms.

Sources

This page was written from the guidance below and checked against it on . Links are re-checked at each review — see our editorial standards.

  1. ASCO (Cancer.Net). Survivorship
  2. National Comprehensive Cancer Network. NCCN Guidelines for Patients
  3. Macmillan Cancer Support. Lymphoedema
  4. European Society of Cardiology (2022). Guidelines on cardio-oncology
  5. National Cancer Institute (US). Late effects of cancer treatment